Non-Small Cell Lung Cancer: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 67-year-old Chinese woman who presents at diagnosis with a moderate smoking history of ½ ppd for 15 years presented with episodes of cough, low-grade fever with weight loss in May 2014. Evaluation including a CT chest and PET/CT revealed a 4 cm mass with some bronchial obstruction and associated atelectasis of the lingular portion of the left upper lobe. Pathology showed a NSCLC with squamous differentiation

Originally posted on a forum in the ASCO Connection, users now have the opportunity to claim CME, MOC, completion, or participation certificates for completing this activity.

Learning Objectives

  • Recognize the need for guideline-supported expanded molecular testing, including MET molecular alterations in the management of patients with advanced NSCLC
  • List the range of appropriate diagnostic modalities for the assessment of MET molecular alterations including MET exon 14 skipping and MET amplification
  • Identify the available treatment options including commercially available and experimental therapies that can be offered for patients identified with MET molecular aberrations

Target Audience
This course is designed for members of the cancer care team including medical, radiation and surgical oncologists, pathologists, and oncology fellows.